Abdulrahman Mujalli
Mecca, 24382, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Correction: Untargeted metabolomics reveals distinct biomarkers and metabolic alterations in familial and non-genetic hypercholesterolemia in Saudi patients.
Journal: Frontiers in medicine
Published: February 25, 2026
Leukemia Incidence and Demographic Trends in Saudi Arabia, 1997-2022: A Nationwide Registry Analysis.
Journal: Journal of epidemiology and global health
Published: August 25, 2025
Forecasting the incidence of acute lymphoid leukaemia in males and females in the Saudi population from 2020 to 2029: application of ARIMA models and public health implications.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 24, 2025
Untargeted metabolomics reveals distinct biomarkers and metabolic alterations in familial and non-genetic hypercholesterolemia in Saudi patients.
Journal: Frontiers in medicine
Published: July 21, 2025
Pathogenic LDLR Variants (c.103 C>T and c.2416dup) in ligand-binding and cytosolic domains in Saudi familial hypercholesterolemia: Molecular characterization and computational insights.
Journal: Computational and structural biotechnology journal
Published: May 14, 2025
Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets.
Journal: Discover oncology
Published: January 21, 2025
Key Disease-Related Genes and Immune Cell Infiltration Landscape in Inflammatory Bowel Disease: A Bioinformatics Investigation.
Journal: International journal of molecular sciences
Published: July 19, 2024
Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction-associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways.
Journal: International journal of experimental pathology
Published: July 12, 2024
A Quest for Potential Role of Vitamin D in Type II Diabetes Mellitus Induced Diabetic Kidney Disease.
Journal: Current pharmaceutical design
Published: December 01, 2023
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.
Journal: International journal of molecular sciences
Published: November 16, 2023
Last Updated: 09/26/2026